ABSTRACT
Monitoring of the neurocritical in the perioperatory is in constant evolution. There are essentially two ultrasonographic application of neuromonitoring: the diameter of the sheath of the optic nerve and transcranial Doppler. Ultrasound-guided neuromonitoring can detect stenosis or occlusion of intracranial arteries, monitor the evolution of patients with vasospasm after subarachnoid hemorrhage, detect cerebral embolism, evaluate the cerebral collateral system, determine brain death, calculate indirectly Intracranial pressure and cerebral perfusion and helps in clinical decisions and early therapeutic interventions in neurocritical care. The purpose of this review is to present the applications of ultrasonography to the head of the patient in neuromonitoring.
El monitoreo del paciente neurocrítico en el perioperatorio se encuentra en constante evolución. Existen fundamentalmente dos evaluaciones ultrasonográficas de neuromonitoreo: el diámetro de la vaina del nervio óptico y el Doppler transcraneal. En la actualidad, el neuromonitoreo guiado por ultrasonido permite detectar estenosis u oclusión de arterias intracraneales, monitorizar la evolución de los enfermos que presentan vasoespasmo tras una hemorragia subaracnoidea, detectar embolias cerebrales, evaluar el sistema colateral cerebral, determinar la muerte cerebral, calcular de manera indirecta la presión intracraneana y la perfusión cerebral, entre otras, y de esta manera poder tomar decisiones terapéuticas tempranas en el manejo del paciente neurocrítico. El motivo de esta revisión es dar a conocer las aplicaciones de la ultrasonografía a la cabecera del enfermo en neuromonitoreo.
Subject(s)
Cerebrovascular Disorders/diagnostic imaging , Intraoperative Neurophysiological Monitoring/methods , Neuroimaging/methods , Optic Nerve/diagnostic imaging , Perioperative Care/methods , Ultrasonography, Doppler, Transcranial , Brain Death/diagnostic imaging , Brain Injuries, Traumatic/diagnostic imaging , Cerebrovascular Circulation/drug effects , Clinical Decision-Making , Humans , Intracranial Pressure , Orbit/diagnostic imaging , Pulsatile Flow , Subarachnoid Hemorrhage/diagnostic imaging , Vasoconstrictor Agents/pharmacology , Vasospasm, Intracranial/diagnostic imagingABSTRACT
Diffuse alveolar hemorrhage (DAH) is a serious pulmonary complication in patients with autoimmune diseases who are undergoing chemotherapy or have had hematopoietic stem cell transplantation. The use of recombinant factor VIIa (rFVIIa) to treat the acute phase of DAH by endobronchial bronchoscopy has been shown to have a significant clinical impact on the survival and evolution of these patients. We report a clinical case of a patient with DAH secondary to systemic lupus erythematosus (SLE) who was treated with rFVIIa administered using a jet nebulizer, obtaining an adequate hemostatic effect with immediate control of DAH and a significant improvement in gas exchange.
